Lannett Announces Expanded Agreement With Strategic Alliance Partner, HEC Pharm Group, To Distribute Two FDA-Approved Products

Company Has Commenced Launch of Clarithromycin and Expects to Begin Marketing Entacapone In Early Calendar Year 2019 PHILADELPHIA, Nov. 6, 2018 -- (Healthcare Sales & Marketing Network) -- Lannett Company, Inc. (NYSE: LCI) today announced that it has e... Biopharmaceuticals, Licensing, Distribution Lannett Company, Sunshine Lake, HEC Pharm Group, clarithromycin, entacapone
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news